BTIG Research Issues Positive Forecast for Tempus AI (NASDAQ:TEM) Stock Price

Key Points

• BTIG Research has increased its target price for Tempus AI (NASDAQ:TEM) from $85.00 to $96.00, indicating a potential upside of 7.74% from its current price.
• Multiple brokerages, including Guggenheim and HC Wainwright, have also given buy ratings for Tempus AI, with revised target prices ranging from $95.00 to $98.00.
• Despite strong quarterly earnings, which topped estimates with revenue up 89.5% year-over-year, Tempus AI has a consensus rating of Hold with an average price target of $76.69.

Tempus AI (NASDAQ:TEM - Get Free Report) had its target price upped by analysts at BTIG Research from $85.00 to $96.00 in a report issued on Wednesday,Benzinga reports. The firm currently has a "buy" rating on the stock. BTIG Research's price objective suggests a potential upside of 7.74% from the company's current price.

Several other brokerages have also recently commented on TEM. Guggenheim raised their target price on Tempus AI from $80.00 to $95.00 and gave the stock a "buy" rating in a research report on Friday, September 26th. HC Wainwright raised their target price on Tempus AI from $90.00 to $98.00 and gave the stock a "buy" rating in a research report on Friday, September 12th. Needham & Company LLC reaffirmed a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research report on Friday, August 8th. Morgan Stanley raised their target price on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. Finally, TD Cowen cut Tempus AI from a "buy" rating to a "hold" rating and set a $88.00 target price for the company. in a research report on Tuesday. Seven research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Tempus AI currently has a consensus rating of "Hold" and an average price target of $76.69.

Tempus AI Stock Performance

TEM opened at $89.10 on Wednesday. The firm has a market cap of $15.48 billion, a PE ratio of -74.87 and a beta of 4.87. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The business has a fifty day simple moving average of $83.27 and a 200-day simple moving average of $66.88. Tempus AI has a fifty-two week low of $31.36 and a fifty-two week high of $104.32.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company's revenue was up 89.5% compared to the same quarter last year. During the same period last year, the company posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities analysts predict that Tempus AI will post -6.15 EPS for the current fiscal year.

Insider Activity at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 17,460 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $1,303,389.00. Following the transaction, the chief operating officer directly owned 839,180 shares in the company, valued at $62,644,787. This trade represents a 2.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction dated Thursday, September 25th. The stock was sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the transaction, the chief executive officer owned 9,141,032 shares in the company, valued at $699,837,409.92. The trade was a 3.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 933,662 shares of company stock valued at $68,070,993. Insiders own 26.27% of the company's stock.

Hedge Funds Weigh In On Tempus AI

A number of institutional investors have recently made changes to their positions in TEM. Vanguard Group Inc. increased its stake in shares of Tempus AI by 6,247.5% in the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock worth $289,204,000 after purchasing an additional 5,900,668 shares during the period. ARK Investment Management LLC increased its stake in shares of Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock worth $361,867,000 after purchasing an additional 1,981,755 shares during the period. Nikko Asset Management Americas Inc. increased its stake in shares of Tempus AI by 31.5% in the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock worth $205,401,000 after purchasing an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after purchasing an additional 1,016,384 shares during the period. Finally, AQR Capital Management LLC bought a new position in shares of Tempus AI in the second quarter worth about $54,020,000. 24.22% of the stock is currently owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.